Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: One Year Follow On and Epitope Mapping (AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013)

(untitled) - Borthwick, N; Ahmed, T; Ondondo, B; Hayton, E; Nicosia, A; McMichael, A; Dorrell, L; Hanke, T